Park Ha Biological Technology Co., Ltd.
PHH
$0.4785
$0.00050.11%
NASDAQ
| 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 619.60K | 619.60K | 764.50K | 764.50K | 426.50K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 619.60K | 619.60K | 764.50K | 764.50K | 426.50K |
| Cost of Revenue | 29.30K | 29.30K | 48.60K | 48.60K | 49.10K |
| Gross Profit | 590.30K | 590.30K | 715.80K | 715.80K | 377.40K |
| SG&A Expenses | 10.44M | 10.44M | 356.90K | 356.90K | 321.20K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 10.48M | 10.48M | 413.80K | 413.80K | 380.30K |
| Operating Income | -9.86M | -9.86M | 350.70K | 350.70K | 46.20K |
| Income Before Tax | -9.83M | -9.83M | 350.10K | 350.10K | 46.60K |
| Income Tax Expenses | 89.50K | 89.50K | 135.20K | 135.20K | 22.20K |
| Earnings from Continuing Operations | -9.92M | -9.92M | 214.80K | 214.80K | 24.50K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -9.92M | -9.92M | 214.80K | 214.80K | 24.50K |
| EBIT | -9.86M | -9.86M | 350.70K | 350.70K | 46.20K |
| EBITDA | -9.85M | -9.85M | 356.40K | 356.40K | 51.80K |
| EPS Basic | -0.37 | -0.37 | 0.01 | 0.01 | 0.00 |
| Normalized Basic EPS | -0.23 | -0.23 | 0.01 | 0.01 | 0.00 |
| EPS Diluted | -0.37 | -0.37 | 0.01 | 0.01 | 0.00 |
| Normalized Diluted EPS | -0.23 | -0.23 | 0.01 | 0.01 | 0.00 |
| Average Basic Shares Outstanding | 26.89M | 26.89M | 25.00M | 25.00M | 25.00M |
| Average Diluted Shares Outstanding | 26.89M | 26.89M | 25.00M | 25.00M | 25.00M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |